Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intermittent Versus Continuous Intravenous Pantoprazole for Prevention of Bleeding After Endoscopic Therapy of Bleeding Peptic Ulcers

NCT03814421 is registered in ClinicalTrials.gov with Samsung Changwon Hospital as lead sponsor.

NCT NCT03814421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03814421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intermittent Versus Continuous Intravenous Pantoprazole for Prevention of Bleeding After Endoscopic Therapy of Bleeding Peptic Ulcers
Lead sponsor
Samsung Changwon Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 15, 2016
Completion date
October 31, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peptic ulcer, peptic ulcer hemorrhage, peptic ulcer, acute with hemorrhage, proton pump inhibitor overdose